These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 26838793)

  • 1. A Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates: Paracrine Activity Without Remuscularization.
    Hu X; Xu Y; Zhong Z; Wu Y; Zhao J; Wang Y; Cheng H; Kong M; Zhang F; Chen Q; Sun J; Li Q; Jin J; Li Q; Chen L; Wang C; Zhan H; Fan Y; Yang Q; Yu L; Wu R; Liang J; Zhu J; Wang Y; Jin Y; Lin Y; Yang F; Jia L; Zhu W; Chen J; Yu H; Zhang J; Wang J
    Circ Res; 2016 Mar; 118(6):970-83. PubMed ID: 26838793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fortune Favors the Prepared: Safety and Efficacy of Allogeneic Hypoxia Preconditioned Mesenchymal Stromal Cells in Primates.
    Kuster GM; Liao R
    Circ Res; 2016 Mar; 118(6):908-10. PubMed ID: 26987910
    [No Abstract]   [Full Text] [Related]  

  • 3. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
    Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
    J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction.
    Zhang Z; Yang C; Shen M; Yang M; Jin Z; Ding L; Jiang W; Yang J; Chen H; Cao F; Hu T
    Stem Cell Res Ther; 2017 Apr; 8(1):89. PubMed ID: 28420436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis.
    Hu X; Yu SP; Fraser JL; Lu Z; Ogle ME; Wang JA; Wei L
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):799-808. PubMed ID: 18374759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction.
    Wang X; Zhen L; Miao H; Sun Q; Yang Y; Que B; Lopes Lao EP; Wu X; Ren H; Shi S; Lau WB; Ma X; Ma C; Nie S
    Theranostics; 2015; 5(9):995-1006. PubMed ID: 26155315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.
    Pasha Z; Wang Y; Sheikh R; Zhang D; Zhao T; Ashraf M
    Cardiovasc Res; 2008 Jan; 77(1):134-42. PubMed ID: 18006467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anoxic preconditioning: a way to enhance the cardioprotection of mesenchymal stem cells.
    Wang JA; He A; Hu X; Jiang Y; Sun Y; Jiang J; Gui C; Wang Y; Chen H
    Int J Cardiol; 2009 Apr; 133(3):410-2. PubMed ID: 18234368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracrine action of mesenchymal stem cells revealed by single cell gene profiling in infarcted murine hearts.
    Yao Y; Huang J; Geng Y; Qian H; Wang F; Liu X; Shang M; Nie S; Liu N; Du X; Dong J; Ma C
    PLoS One; 2015; 10(6):e0129164. PubMed ID: 26043119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction.
    Rahbarghazi R; Nassiri SM; Ahmadi SH; Mohammadi E; Rabbani S; Araghi A; Hosseinkhani H
    Int J Cardiol; 2014 May; 173(3):453-66. PubMed ID: 24679689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
    Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
    Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-inferiority of microencapsulated mesenchymal stem cells to free cells in cardiac repair after myocardial infarction: A rationale for using paracrine factor(s) instead of cells.
    Karpov AA; Puzanov MV; Ivkin DY; Krasnova MV; Anikin NA; Docshin PM; Moiseeva OM; Galagudza MM
    Int J Exp Pathol; 2019 Apr; 100(2):102-113. PubMed ID: 31017330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
    Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
    Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of NUCKS augments paracrine effects of mesenchymal stem cells-mediated cardiac protection.
    Zhang Y; Chiu S; Liang X; Chai YH; Qin Y; Wang J; Li X; Qiu B; Tergaonkar V; Tse HF; Lian Q
    Exp Cell Res; 2017 Jul; 356(1):74-84. PubMed ID: 28412246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance.
    Zeng B; Chen H; Zhu C; Ren X; Lin G; Cao F
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):850-6. PubMed ID: 18640847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats.
    Xie X; Sun A; Zhu W; Huang Z; Hu X; Jia J; Zou Y; Ge J
    Tohoku J Exp Med; 2012 Jan; 226(1):29-36. PubMed ID: 22186034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
    Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
    Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-206 is involved in survival of hypoxia preconditioned mesenchymal stem cells through targeting Pim-1 kinase.
    Zhang Y; Lei W; Yan W; Li X; Wang X; Zhao Z; Hui J; Shen Z; Yang J
    Stem Cell Res Ther; 2016 Apr; 7(1):61. PubMed ID: 27103465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.